The attraction of CSL is the fact that it could do a script deal that would let existing AVX shareholders enjoy the upside of commercialisation. On that basis, they could probably get away with a lower offer than an O/S pharma co.
- Forums
- ASX - By Stock
- AVX
- csl
csl, page-4
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online